or
forgot password
  • cancer clinical trials in sheridan, WY

  • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Melanoma (Skin)
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Breast Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Lymphoma
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Lung Cancer
    Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Prostate Cancer
    Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Breast Cancer
    Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Leukemia
    S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Lung Cancer
    S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Multiple Myeloma, Plasma Cell Myeloma
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Lymphoma
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Metastatic Cancer, Prostate Cancer
    Creatine in Treating Patients With Cancer-Associated Weight Loss
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Leukemia
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Recurrent Mantle Cell Lymphoma
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Breast Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Bladder Cancer
    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Colorectal Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Prostate Cancer
    S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Leukemia
    Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Breast Cancer, Lung Cancer, Metastatic Cancer, Pain, Prostate Cancer
    S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Lung Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Breast Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Breast Cancer, Metastatic Cancer
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Prostate Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Lung Cancer
    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Lung Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Leukemia
    Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Breast Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Welch Cancer Center
    Sheridan, Wyoming 82801
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
    Welch Cancer Center at Sheridan Memorial Hospital
    Sheridan, Wyoming 82801
    Brain and Central Nervous System Tumors
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Welch Cancer Center
    Sheridan, Wyoming 82801
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Welch Cancer Center
    Sheridan, Wyoming 82801
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia